Propelevate will leverage our experience expanding access to women’s health products around the world, ensuring that Vivacelle Bio’s innovations are designed for and with Sub-Saharan African health care providers and users, and that products are available within regional markets quickly.

Life sciences company Vivacelle Bio today announced Sub-Saharan Africa as a priority region for its life-saving alternative to fluid resuscitation to treat hypovolemia caused by severe sepsis, septic shock, or blood loss.

There are three major reasons to include diverse global markets as soon as possible in your product/service development strategy.

Reason 1: It’s where your customers are

Reason 2: You can address need and inequity

Reason 3: There are partners that can make it easier

We also share thoughts on how to incorporate a health equity lens in new markets.